The Madras High Court, via judgement dated October 22, 2024, in Regeneron Pharmaceuticals Inc vs. Controller of Patents and Designs [(T)CMA(PT) No.191 of 2023] addressed an appeal under Section 3(b) and 59 of the Patents Act (Act) by Regeneron Pharmaceuticals challenging the Indian Patent Office’s (IPO) refusal order dated December 16, 2020 issued in respect of their Indian Patent Application No. 1554/CHENP/2013.
Continue reading “Court Emphasizes Reasoned Decisions: Regeneron Pharmaceuticals Inc vs. Controller of Patents and Designs”
MehtaIP 